Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Cipla launches Niveoli™, India's first extrafine ICS-LABA combination HFA inhaler

Posted On: 2019-04-12 09:10:41

Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") announces that it has launched Niveoli™, India's first extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, targeting drug delivery to the small airways. Niveoli™ is a proprietary Cipla inhaler, and the latest offering from Cipla in respiratory inhalation therapy that addresses an unmet need associated with obstructive airway diseases (OAD) such as asthma and chronic obstructive pulmonary disorder (COPD).

Asthma and COPD are lung conditions that affect the ability to breathe. Extensive research and an evolved understanding of the diseases over the years has shown the significant role of small airway disease in asthma and COPD. A recent meta-analysis showed that small airway disease is prevalent in 50-60% of asthma patients1. Another study has indicated that routine lung function tests can underestimate problems in the small airways2. Small airway disease is a common feature of COPD and gets worse with increasing severity of the condition3. Niveoli™'s novelty and strength lies in HFA propelled delivery of extra-fine particles of beclomethasone, an inhaled corticosteroid (ICS) and formoterol, a fast-onset long acting beta agonist (LABA) to the small airways.

Commenting on the launch, Nikhil Chopra, Head - India business, Cipla, said, "Cipla is pleased to offer yet another milestone in respiratory inhalation therapy. Niveoli™ marks a first in acknowledging and addressing the issue of drug delivery to the small airways. Cipla has a long history of blazing the trail in innovations in combination formulations and drug-device combinations in the respiratory therapy, and Niveoli™ is a painstaking result of these strengths. Be it the transparent dry powder inhaler, the static-free spacer with valve mechanism, the mask-spacer combination for children or our novel breath-actuated inhaler with dose counter called Synchrobreathe™, the list is long. We see our market leadership as well as the range and depth of our R&D and manufacturing capabilities in this therapy as a privilege and a responsibility to do more for patients. In keeping with our purpose of 'Caring for Life', we are constantly studying OADs and working towards products that offer greater efficacy, ease of use and drug delivery to patients. I believe Niveoli™ represents a new paradigm in inhalation therapy."

Shares of CIPLA LTD. was last trading in BSE at Rs.544.35 as compared to the previous close of Rs. 546.15. The total number of shares traded during the day was 125596 in over 2113 trades.

The stock hit an intraday high of Rs. 554.4 and intraday low of 542.25. The net turnover during the day was Rs. 68868583.

1 Respir Med 2016; 116: 19-27
2 Respir Med 2013; 107: 1667-1674
3 Am J Respir Crit Care Med 2016; 194: 178-184


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

BHEL wins Rs.800 crore EPC orders for 200 MW Solar Power Plants

Pricol Ltd announces changes in board

The South Indian Bank Ltd board approves debt issue of up to Rs. 500 crores

Sandhar Technologies Ltd signs JV agreement with Winnercom Co. Ltd.

Tenure of 6 independent directors of NBCC India Ltd ends

Super Spinning Mills Ltd announces resignation of directors

Pricol Limited announces financial results for Q4 FY 2018-19

Elecon Engineering Company Ltd bags Rs. 79.12 crores order from BHEL

Fire accident at PG Electroplast Ltd's washing machine division

FDC Limited receives ANDA approval for Dorzolamide and Timolol Ophthalmic Solution USP 22.3Mg/6.83Mg Per Ml

USFDA completes inspection at Unit 2 of Divi's Laboratories Ltd at Chippada

Apcotex Industries Ltd fixes July 5, 2019 as record date for stock split

ICRA updates on credit ratings of Aster DM Healthcare Ltd

GPCB revokes closure notice issued to Coromandel International Ltd's Sarigam unit

Relaxo Footwears Ltd fixes June 27, 2019 as record date for bonus issue

Shriram EPC Ltd approves resignation of nominee director

Bilcare Limited appoints Ms. Madhuri Vidya as women independent director

PSP Projects Ltd's MD & CEO bags CXO of the Year award

Zydus' Nesher Pharmaceuticals receives final approval from the USFDA for Omega-3-Acid Ethyl Esters Capsules

Alidac Pharmaceuticals Ltd receives EIR from USFDA

Reliance Infrastructure Ltd announces FY19 results

Smt. Supriya Prakash Sen co-opted as additional director of Lakshmi Vilas Bank Ltd

Mahindra enters into Strategic Alliance with Switzerland-based Gamaya

CreditAccess Grameen Ltd appoints B R Diwakar as additional director

Voltas launches new Brand Shop at Chackai, Thiruvananthapuram

Ind-Ra revises rating outlook of CCL Products India Ltd

Aplab Ltd appoints independent director

Infosys Ltd board to announce Q1 results on July 12, 2019

USFDA completes inspection at Laurus Labs Ltd's Vizag units

Asian Hotels North Ltd updates on rating downgrade by CRISIL

Siti Networks Ltd appoints Mr. Suresh Kumar Arora as whole time director

M&M updates on investment in Gamaya SA, Switzerland

Maruti Suzuki sets up Water ATM in Naviyani village, Gujarat

G M Breweries Ltd board to consider Q1 results on July 4, 2019

McDonald's comes up with McSaver Snacks Mix n' Match combo offers starting at just Rs 49!

3i Infotech Ltd appoints Mr. Rajeev Kumar Sinha as nominee director of IDBI Bank

Tata Communications divests remaining 26% stake in The Singapore Data Centre Business

Biocon Biologics Facilities In Bengaluru Receive EU GMP Certification

Shri Lakshmi Cotsyn Ltd appoints CFO

Smartlink Holdings Ltd board approves buy back at Rs. 130

Steelco Gujarat Ltd calls for board meeting on July 16, 2019

IDBI Bank initiates Forensic Audit of Sankhya Infotech Ltd

The Indian Wood Product Co. Ltd launches Pan Sugandh - packet of Katha in the state of Bihar

Kapil Uniyal of Birlasoft bags award

Sun Pharma announces Late-Breaking Phase 2 Data Showing Potential of ILUMYA™

Sunteck Realty Ltd appoints CFO

Melstar Information Technologies Ltd announces resignation of CEO

The Indian Wood Product Co. Ltd launches retail packets of Spices in New Delhi and Uttarakhand

Dr. Reddy's Laboratories inks agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC

RITES Ltd board to consider bonus issue on June 24, 2019







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019